Login
- Title:
Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) compari
- Document type:
- Article
- Author(s):
- du Bois, A; Sehouli, J; Lund, B; Joly, E; Huober, J; Jensen, TS; Levy, E; Heilmann, V; Boman, K; Hardy-Bessard, AC; Burges, A; Maenpaa, J; Pujade-Lauraine, E; Pfisterer, J; Gropp, M; Staehle, A; Wimberger, P; Jackisch, C; Schmalfeldt, B; Belau, A; Loibl, S; Wollschlaeger, K; Canzler, U; Rochon, J
- Journal title abbreviation:
- Int J Gynecol Cancer
- Year:
- 2005
- Journal volume:
- 15 Suppl.
- Pages contribution:
- 224-225
- Language:
- eng
- Print-ISSN:
- 1048-891X
- TUM Institution:
- Frauenklinik und Poliklinik
BibTeX